Zenotech Laboratories Limited has scheduled a meeting of its Board of Directors for Wednesday, October 28, 2026. The primary agenda for this meeting is to consider and approve the company's Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026.
Regarding trading restrictions, the company confirms that the Trading Window for dealing in the company's shares has been closed effective from Thursday, October 01, 2026, as previously communicated on September 26, 2026. The trading window will remain closed until 48 hours after the declaration of the financial results, specifically through and including Friday, October 30, 2026.
This disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is signed by Abdul Gafoor Mohammad, Company Secretary & Compliance Officer (ICSI Membership No.: A22331).